Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) EBT (2016 - 2025)

CV Sciences' EBT history spans 14 years, with the latest figure at -$382000.0 for Q3 2025.

  • For Q3 2025, EBT rose 16.23% year-over-year to -$382000.0; the TTM value through Sep 2025 reached -$1.5 million, up 41.54%, while the annual FY2024 figure was -$2.4 million, 177.58% down from the prior year.
  • EBT for Q3 2025 was -$382000.0 at CV Sciences, down from -$261000.0 in the prior quarter.
  • Across five years, EBT topped out at $5.7 million in Q1 2023 and bottomed at -$9.0 million in Q4 2021.
  • The 5-year median for EBT is -$740000.0 (2024), against an average of -$1.2 million.
  • The largest annual shift saw EBT plummeted 2477.5% in 2022 before it skyrocketed 476.63% in 2023.
  • A 5-year view of EBT shows it stood at -$9.0 million in 2021, then skyrocketed by 73.62% to -$2.4 million in 2022, then soared by 62.83% to -$878000.0 in 2023, then increased by 15.72% to -$740000.0 in 2024, then soared by 48.38% to -$382000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's EBT are -$382000.0 (Q3 2025), -$261000.0 (Q2 2025), and -$102000.0 (Q1 2025).